You are here : Home / Products / GPCRs / cAMP cell-based assay

cAMP cell-based assay

Cyclic AMP:  the unique GPCR Gi/s second messenger accumulation assay

Cisbio Bioassays offers a line of three ready-to-use assays for measuring cAMP using HTRF® technology. Each kit is optimized for the detection of a specific range of cAMP concentrations, to enable assay sensitivity  fine tuning. These kits give high quality, cell-based assay screening in 96-, 384- or 1536-well formats.

Features

  • Cell-based functional assay
  • Second messenger accumulation assay
  • Assay formats 100 µL and 20 µL
  • Miniaturization down to < 10µl
  • Compatible with fresh or frozen cells

Applications

  • Gs or Gi coupled receptor activation
  • Assess agonists, antagonists, inverse agonists and allosteric modulators
  • Phosphodiesterase (PDE) monitoring
  • Adenylate cyclase activity assessment
ask for a quote contact us

cAMP kits are based on a competitive immunoassay using cryptate-labeled anti-cAMP and d2-labeled cAMP. The dye d2 is our newest HTRF® acceptor fluorophore.

cAMP two step protocol, after cell stimulation

Three kit groups to cover a broad range of cell-based assays.

cAMP femto kits

cAMP femto kits are the most sensitive cAMP cell-based assays. With the introduction of Lumi4®-Tb cryptate, cAMP femto is now available with two cryptates (europium or terbium). Both kits enable the detection of as little as 28 pM cAMP (0.6 fmoles/well in 20µl volume).

cAMP dynamic 2

cAMP dynamic 2 covers a wide range of cAMP concentrations. This kit is ideal for a broad range of Gi/s assays.

cAMP HiRange

With an extended signal-to-background ratio and Z' > 0.9, cAMP HiRange is streamlined for HTS. The antibody does not cross-react with ATP. membrane preparations

  Cryptate S/B IC20 nM* IC50 nM* IC80 nM*
cAMP femto Kit Eu3+ >8 0.33 1.76 9.4
cAMP femto Tb Kit Tb2+ >8 0.33 1.76 9.4
cAMP dynamic 2 Kit Eu3+ >14 0.91 4.07 18.1
cAMP HiRange Kit Eu3+ >28 4.27 22.8 1.21

* final cAMP concentration

Ordering Info

DescriptionCat. noProduct insertMSDS
cAMP dynamic 2 kit - 1,000 tests62AM4PEBpdfpdf
cAMP dynamic 2 kit - 20,000 tests62AM4PECpdfpdf
cAMP dynamic 2 kit -2 X 96 tests62AM4PEFpdfpdf
cAMP dynamic 2 kit - 100,000 tests62AM4PEJpdfpdf
cAMP dynamic 2 kit -1 M tests (10 packs 62AM4PEJ)62AM4PEMpdfpdf
cAMP femto 2 kit - 1,000 tests62AM5PEBpdfpdf
cAMP femto 2 kit - 20,000 tests62AM5PECpdfpdf
cAMP femto 2 kit - 100,000 tests62AM5PEJpdfpdf
cAMP HiRange kit - 1,000 tests62AM6PEBpdfpdf
cAMP HiRange kit - 20,000 tests62AM6PECpdfpdf
cAMP HiRange kit - 100,000 tests62AM6PEJpdfpdf
cAMP HiRange kit - 1 M tests (10 packs 62AM6PEJ)62AM6PEMpdfpdf
cAMP femto Tb kit - 1,000 tests62AM7PEBpdfpdf
cAMP femto Tb kit - 20,000 tests62AM7PECpdfpdf
cAMP femto Tb kit - 100,000 tests62AM7PEJpdfpdf
Lysis buffer 2 (cAMP/cGMP kits 20, & 100,000 tests)62CL2FDF--

Companion products

DescriptionCat. noProduct insertMSDS
cAMP dynamic 2 calibrator 62AM4CDA-pdf
cAMP dynamic 2 control 62AM4TDA-pdf
cAMP femto 2 calibrator 62AM5CDA-pdf
cAMP femto 2 control 62AM5TDA-pdf
cAMP HiRange calibrator 62AM6CDA-pdf
cAMP HiRange control 62AM6TDA-pdf
Lysis buffer 1 (cAMP/cGMP kits 1,000 tests) - 13 ml62CL1FDD--
Lysis buffer 2 (cAMP/cGMP kits 20, & 100,000 tests)62CL2FDF--
96 half-well white plate cell culture - 8 plates66PL8ZZZ--

View all

Title

Related products

Download

Biased agonism of the calcium-sensing receptor
Thomsen AR, Hvidtfeldt M, Bräuner-Osborne H.
Cell Calcium. 2012;51(2):107-16.
The mechanism of action of doxofylline is unrelated to HDAC inhibition, PDE inhibition or adenosine receptor antagonism
van Mastbergen J, Jolas T, Allegra L, Page CP
Pulm Pharmacol Ther. 2012 Feb;25(1):55-61
Discovery of a second generation agonist of the orphan G-protein coupled receptor GPR119 with an improved profile
Semple G, Lehmann J, Wong A, Ren A, Bruce M, Shin YJ, Sage CR, Morgan M, Chen WC, Sebring K, Chu ZL, Leonard JN, Al-Shamma H, Grottick AJ, Du F, Liang Y, Demarest K, Jones RM.
Bioorg Med Chem Lett. 2011 Dec 30.
Biomimetic screening of class-B G protein-coupled receptors
Devigny C, Perez-Balderas F, Hoogeland B, Cuboni S, Wachtel R, Mauch CP, Webb KJ, Deussing JM, Hausch F
J Am Chem Soc. 2011 Jun 15;133(23):8927-33
Inhibition of morphine-induced cAMP overshoot: a cell-based assay model in a high-throughput format
Xia M, Guo V, Huang R, Shahane SA, Austin CP, Nirenberg M, Sharma SK.
Cell Mol Neurobiol. 2011 Aug;31(6):901-7.
G protein activation by serotonin type 4 receptor dimers: evidence that turning on two protomers is more efficient
Pellissier LP, Barthet G, Gaven F, Cassier E, Trinquet E, Pin JP, Marin P, Dumuis A, Bockaert J, Banères JL, Claeysen S.
J Biol Chem. 2011 Mar 25;286(12):9985-97.
Selective orthosteric free fatty acid receptor 2 (FFA2) agonists: identification of the structural and chemical requirements for selective activation of FFA2 versus FFA3
Schmidt J, Smith NJ, Christiansen E, Tikhonova IG, Grundmann M, Hudson BD, Ward RJ, Drewke C, Milligan G, Kostenis E, Ulven T
J Biol Chem. 2011;286(12):10628-40.
THRX-198321 is a bifunctional muscarinic receptor antagonist and beta2-adrenoceptor agonist (MABA) that binds in a bimodal and multivalent manner
Steinfeld T, Hughes AD, Klein U, Smith JA, Mammen M.
Mol Pharmacol. 2011;79(3):389-99.
Mouse monoclonal antibodies to anthrax edema factor protect against infection
Leysath CE, Chen KH, Moayeri M, Crown D, Fattah R, Chen Z, Das SR, Purcell RH, Leppla SH.
Infect Immun. 2011 Nov;79(11):4609-16.
Drug to genome to drug: discovery of new antiplasmodial compounds
Beghyn TB, Charton J, Leroux F, Laconde G, Bourin A, Cos P, Maes L, Deprez B.
J Med Chem. 2011;54(9):3222-40
Biphasic suppression of appetite by cannabinoid CB1 receptor antagonists with distinct functional activities
Lin Y, Shia KS, Hsiao WC, Hsieh WP, Yeh TK, Tseng SL, Hsu CY, Chao YS, Hung MS
Pharmacol Res. 2010;62(4):337-43.
Identification and characterization of a small molecule antagonist of human VPAC(2) receptor
Chu A, Caldwell JS, Chen YA
Mol Pharmacol. 2010;77(1):95-101.
Evaluation of nonradioactive cell-free cAMP assays for measuring in vitro phosphodiesterase activity
Eapen MS, Sodhi R, Balakrishnan G, Dastidar S, Ray A, Vijayakrishnan L
Pharmacology. 2010;85(5):280-285.
Subtlety of the structure-affinity and structure-efficacy relationships around a nonpeptide oxytocin receptor agonist.
Frantz MC, Rodrigo J, Boudier L, Durroux T, Mouillac B, Hibert M.
J Med Chem. 2010 Feb 25;53(4):1546-62.
Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptor.
Jiang J, Ganesh T, Du Y, Thepchatri P, Rojas A, Lewis I, Kurtkaya S, Li L, Qui M, Serrano G, Shaw R, Sun A, Dingledine R
Proc Natl Acad Sci U S A. 2010;107(5):2307-12.
A uHTS approach for the identification of beta-adrenoceptor ligands.
Tasler S, Baumgartner R, Aschenbrenner A, Ammendola A, Wolf K, Wieber T, Schachtner J, Blisse M, Quotschalla U, Ney P
Bioorg Med Chem Lett. 2010;20(11):3399-404.
The metabotropic glutamate receptor mGlu7 activates phospholipase C, translocates munc-13-1 protein, and potentiates glutamate release at cerebrocortical nerve terminals
Martín R, Durroux T, Ciruela F, Torres M, Pin JP, Sánchez-Prieto J.
J Biol Chem. 2010;285(23):17907-17.
GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models.
Lu X, Roberts E, Xia F, Sanchez-Alavez M, Liu T, Baldwin R, Wu S, Chang J, Wasterlain CG, Bartfai T
Proc Natl Acad Sci U S A. 2010;107(34):15229-34.
Fully human monoclonal antibodies antagonizing the glucagon receptor improve glucose homeostasis in mice and monkeys
Yan H, Gu W, Yang J, Bi V, Shen Y, Lee E, Winters KA, Komorowski R, Zhang C, Patel JJ, Caughey D, Elliott GS, Lau YY, Wang J, Li YS, Boone T, Lindberg RA, Hu S, Véniant MM.
J Pharmacol Exp Ther. 2009;329(1):102-11.
Inhibition of heterotrimeric G protein signaling by a small molecule acting on Galpha subunit.
Ayoub MA, Damian M, Gespach C, Ferrandis E, Lavergne O, De Wever O, Baneres JL, Pin JP, Prevost GP
J Biol Chem. 2009;284(42):29136-45.
Anorexia induced by activation of serotonin 5-HT4 receptors is mediated by increases in CART in the nucleus accumbens
Jean A, Conductier G, Manrique C, Bouras C, Berta P, Hen R, Charnay Y, Bockaert J, Compan V
Proc Natl Acad Sci U S A. 2007;104(41):16335-40
Real-Time Analysis of Agonist-Induced Activation of Protease-Activated Receptor 1/Galpha i1 Protein Complex Measured by Bioluminescence Resonance Energy Transfer in Living Cells
Ayoub MA, Maurel D, Binet V, Fink M, Prézeau L, Ansanay H, Pin JP.
Mol Pharmacol. 2007;71(5):1329-40
Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor.
Soga T, Ohishi T, Matsui T, Saito T, Matsumoto M, Takasaki J, Matsumoto S, Kamohara M, Hiyama H, Yoshida S, Momose K, Ueda Y, Matsushime H, Kobori M, Furuichi K
Biochem Biophys Res Commun. 2005;326(4):744-51.
High throughput screening technologies for direct cyclic AMP measurement.
Gabriel D, Vernier M, Pfeifer MJ, Dasen B, Tenaillon L, Bouhelal R
Assay Drug Dev Technol. 2003;1(2):291-303.
HTRF® a versatil approach for 7TM drug discovery
Kamal A
SLAS 2012, San Diego, California, USA
Ultra high throughput GPCR screening utilizing CCD imaging systems with HTRF®
Feighner S
HTRF® 3rd Annual Symposium 2007, Sonoma, CA, USA
Comparison of two Homogenous Time-Resolved Fluorescence (HTRF®) assays for high throughput screening of a natural product library
Jobling MF, Fechner GA, Quinn RJ, Avery VM
HTRF® 3rd Annual Symposium 2007, Sonoma, CA, USA
cAMP Fresh and Frozen Cell Usage
Watson J
SBS 12th Annual Conference. September 2006, Seattle, USA
Identification and pharmacological characterisation of novel positive allosteric modulators (PAMs) of Melanocortin 3 Receptors
Jerman J, Cook J, Forfar R, Wright P , Taylor D, Perretti M, Montero-Melendez T, Kamal A
4th BPS focused meeting on Cell Signaling, leicester, United Kingdom
Application of Bioassay performance. Monitoring process with Statistical Tools
Shi L, Subbarao M, Pai H, Miller L
SBS 13th annual conference. April 2007, Montreal, Canada
Homogeneous High Throughput Live Cell GPCR Functional and Surface Binding Assays
Sirenko O, N'Garwate E, Tardieu JL, Lebreton ML, Jaga D, Katzlinger M, Monnet L, Cardonnel C, Olsen C, Degorce F, Cromwell EF"
Full characterization of Opioid receptors using Tag-lite® and HTRF® Technologies on a CyBio Robotic Platform
Jean A, Romier M, Mazille M, Nicolas L, Bdioui S, Barnouin T, Chevallier F, Preaudat M
Miptec 2010, Basel, Switzerland
Investigations of Tag-lite applications for screening biotherapeutics on cell surface protein targets
Mokrane H, Seguin P, Vallague J, Maurin F, Gregor N,Trinquet E, Degorce F
Miptec 2010, Basel, Switzerland
Inverse agonist properties of the A2A adenosine receptor antagonist IBMX in HEK 293 cells
Piwnica D, Wang SR, Jolas T, Néliat G, Fouchaq B
SBS 13th annual conference. April 2007, Montreal, Canada
Quantitative evaluation of sodium butyrate on dual coupling of human muscarinic receptor M4
Wang SR, Piwnica D, Jolas T, Néliat G, Fouchaq B
SBS 13th annual conference. April 2007, Montreal, Canada
cAMP and TNFα assays on Synergy 2.
Held P, Chevallier F, Jean A, Amouretti X
SBS 13th annual conference. April 2007, Montreal, Canada
Identification of human endogenous calcitonin receptor in 293H cell line : characterization by cyclic AMP measurement
Sabatier R, Wang SR, Piwinca D, Jolas T, Fouchaq B
SBS 13th annual conference. April 2007, Montreal, Canada
HTRF® cAMP Dynamic 2 and IP-One Assays Using the SpectraMax M5e Multi-Detection Microplate Reader
An Application Note from Molecular Devices corporation
Quantitate cAMP and Tumor Necrosis Factor Utilizing the Synergy™ 2 Multi-Detection Microplate Reader and HTRF®: Assays for High-Throughput Screening
An Application Note from BioTek Instruments
Implementation of HTRF® on Tecan Safire²™
An Application Note from TECAN
Implementation of HTRF® on Tecan GENIos Pro. Human TNFα and cAMP kit, CIS bio international.
An Application Note from TECAN
Implementation of HTRF® on Tecan Ultra Evolution
An Application Note from TECAN
Artemis: the new HTRF® reader designed for the life science field
An Application Note from Berthold technologies
Implementation of HTRF® on Tecan Safire2™. cAMP Hirange kit, Cisbio Bioassays

An Application Note from TECAN
Comparison of HTRF® compatible readers from Tecan. Ultra Evolution™, GENios Pro™ & Safire²™ - cAMP HiRange kit.

An Application Note from TECAN
cAMP and IP-One HTRF assays on the new SpectraMax M5e multi-detection
An Application Note from Molecular Devices corporation
cAMP/IP-One HTplex cell-based experiment performed on Mithras LB 940 using HTRF® technology
An Application Note from Berthold technologies
Implementation of HTRF® on Tecan Ultra Evolution. Human TNF&alpha and cAMP kit, CIS bio international

An Application Note from TECAN

Application note13

Title

Related products

Download

HTRF® cAMP Dynamic 2 and IP-One Assays Using the SpectraMax M5e Multi-Detection Microplate Reader
An Application Note from Molecular Devices corporation
Quantitate cAMP and Tumor Necrosis Factor Utilizing the Synergy™ 2 Multi-Detection Microplate Reader and HTRF®: Assays for High-Throughput Screening
An Application Note from BioTek Instruments
Implementation of HTRF® on Tecan Safire²™
An Application Note from TECAN
Implementation of HTRF® on Tecan GENIos Pro. Human TNFα and cAMP kit, CIS bio international.
An Application Note from TECAN
Implementation of HTRF® on Tecan Ultra Evolution
An Application Note from TECAN
Artemis: the new HTRF® reader designed for the life science field
An Application Note from Berthold technologies
Implementation of HTRF® on Tecan Safire2™. cAMP Hirange kit, Cisbio Bioassays

An Application Note from TECAN
Comparison of HTRF® compatible readers from Tecan. Ultra Evolution™, GENios Pro™ & Safire²™ - cAMP HiRange kit.

An Application Note from TECAN
cAMP and IP-One HTRF assays on the new SpectraMax M5e multi-detection
An Application Note from Molecular Devices corporation
cAMP/IP-One HTplex cell-based experiment performed on Mithras LB 940 using HTRF® technology
An Application Note from Berthold technologies
Implementation of HTRF® on Tecan Ultra Evolution. Human TNF&alpha and cAMP kit, CIS bio international

An Application Note from TECAN

Poster9

Title

Related products

Download

Identification and pharmacological characterisation of novel positive allosteric modulators (PAMs) of Melanocortin 3 Receptors
Jerman J, Cook J, Forfar R, Wright P , Taylor D, Perretti M, Montero-Melendez T, Kamal A
4th BPS focused meeting on Cell Signaling, leicester, United Kingdom
Application of Bioassay performance. Monitoring process with Statistical Tools
Shi L, Subbarao M, Pai H, Miller L
SBS 13th annual conference. April 2007, Montreal, Canada
Homogeneous High Throughput Live Cell GPCR Functional and Surface Binding Assays
Sirenko O, N'Garwate E, Tardieu JL, Lebreton ML, Jaga D, Katzlinger M, Monnet L, Cardonnel C, Olsen C, Degorce F, Cromwell EF"
Full characterization of Opioid receptors using Tag-lite® and HTRF® Technologies on a CyBio Robotic Platform
Jean A, Romier M, Mazille M, Nicolas L, Bdioui S, Barnouin T, Chevallier F, Preaudat M
Miptec 2010, Basel, Switzerland
Investigations of Tag-lite applications for screening biotherapeutics on cell surface protein targets
Mokrane H, Seguin P, Vallague J, Maurin F, Gregor N,Trinquet E, Degorce F
Miptec 2010, Basel, Switzerland
Inverse agonist properties of the A2A adenosine receptor antagonist IBMX in HEK 293 cells
Piwnica D, Wang SR, Jolas T, Néliat G, Fouchaq B
SBS 13th annual conference. April 2007, Montreal, Canada
Quantitative evaluation of sodium butyrate on dual coupling of human muscarinic receptor M4
Wang SR, Piwnica D, Jolas T, Néliat G, Fouchaq B
SBS 13th annual conference. April 2007, Montreal, Canada
cAMP and TNFα assays on Synergy 2.
Held P, Chevallier F, Jean A, Amouretti X
SBS 13th annual conference. April 2007, Montreal, Canada
Identification of human endogenous calcitonin receptor in 293H cell line : characterization by cyclic AMP measurement
Sabatier R, Wang SR, Piwinca D, Jolas T, Fouchaq B
SBS 13th annual conference. April 2007, Montreal, Canada

Presentation5

Title

Related products

Download

HTRF® a versatil approach for 7TM drug discovery
Kamal A
SLAS 2012, San Diego, California, USA
Ultra high throughput GPCR screening utilizing CCD imaging systems with HTRF®
Feighner S
HTRF® 3rd Annual Symposium 2007, Sonoma, CA, USA
Comparison of two Homogenous Time-Resolved Fluorescence (HTRF®) assays for high throughput screening of a natural product library
Jobling MF, Fechner GA, Quinn RJ, Avery VM
HTRF® 3rd Annual Symposium 2007, Sonoma, CA, USA
cAMP Fresh and Frozen Cell Usage
Watson J
SBS 12th Annual Conference. September 2006, Seattle, USA

Scientific paper25

Title

Related products

Download

Biased agonism of the calcium-sensing receptor
Thomsen AR, Hvidtfeldt M, Bräuner-Osborne H.
Cell Calcium. 2012;51(2):107-16.
The mechanism of action of doxofylline is unrelated to HDAC inhibition, PDE inhibition or adenosine receptor antagonism
van Mastbergen J, Jolas T, Allegra L, Page CP
Pulm Pharmacol Ther. 2012 Feb;25(1):55-61
Discovery of a second generation agonist of the orphan G-protein coupled receptor GPR119 with an improved profile
Semple G, Lehmann J, Wong A, Ren A, Bruce M, Shin YJ, Sage CR, Morgan M, Chen WC, Sebring K, Chu ZL, Leonard JN, Al-Shamma H, Grottick AJ, Du F, Liang Y, Demarest K, Jones RM.
Bioorg Med Chem Lett. 2011 Dec 30.
Biomimetic screening of class-B G protein-coupled receptors
Devigny C, Perez-Balderas F, Hoogeland B, Cuboni S, Wachtel R, Mauch CP, Webb KJ, Deussing JM, Hausch F
J Am Chem Soc. 2011 Jun 15;133(23):8927-33
Inhibition of morphine-induced cAMP overshoot: a cell-based assay model in a high-throughput format
Xia M, Guo V, Huang R, Shahane SA, Austin CP, Nirenberg M, Sharma SK.
Cell Mol Neurobiol. 2011 Aug;31(6):901-7.
G protein activation by serotonin type 4 receptor dimers: evidence that turning on two protomers is more efficient
Pellissier LP, Barthet G, Gaven F, Cassier E, Trinquet E, Pin JP, Marin P, Dumuis A, Bockaert J, Banères JL, Claeysen S.
J Biol Chem. 2011 Mar 25;286(12):9985-97.
Selective orthosteric free fatty acid receptor 2 (FFA2) agonists: identification of the structural and chemical requirements for selective activation of FFA2 versus FFA3
Schmidt J, Smith NJ, Christiansen E, Tikhonova IG, Grundmann M, Hudson BD, Ward RJ, Drewke C, Milligan G, Kostenis E, Ulven T
J Biol Chem. 2011;286(12):10628-40.
THRX-198321 is a bifunctional muscarinic receptor antagonist and beta2-adrenoceptor agonist (MABA) that binds in a bimodal and multivalent manner
Steinfeld T, Hughes AD, Klein U, Smith JA, Mammen M.
Mol Pharmacol. 2011;79(3):389-99.
Mouse monoclonal antibodies to anthrax edema factor protect against infection
Leysath CE, Chen KH, Moayeri M, Crown D, Fattah R, Chen Z, Das SR, Purcell RH, Leppla SH.
Infect Immun. 2011 Nov;79(11):4609-16.
Drug to genome to drug: discovery of new antiplasmodial compounds
Beghyn TB, Charton J, Leroux F, Laconde G, Bourin A, Cos P, Maes L, Deprez B.
J Med Chem. 2011;54(9):3222-40
Biphasic suppression of appetite by cannabinoid CB1 receptor antagonists with distinct functional activities
Lin Y, Shia KS, Hsiao WC, Hsieh WP, Yeh TK, Tseng SL, Hsu CY, Chao YS, Hung MS
Pharmacol Res. 2010;62(4):337-43.
Identification and characterization of a small molecule antagonist of human VPAC(2) receptor
Chu A, Caldwell JS, Chen YA
Mol Pharmacol. 2010;77(1):95-101.
Evaluation of nonradioactive cell-free cAMP assays for measuring in vitro phosphodiesterase activity
Eapen MS, Sodhi R, Balakrishnan G, Dastidar S, Ray A, Vijayakrishnan L
Pharmacology. 2010;85(5):280-285.
Subtlety of the structure-affinity and structure-efficacy relationships around a nonpeptide oxytocin receptor agonist.
Frantz MC, Rodrigo J, Boudier L, Durroux T, Mouillac B, Hibert M.
J Med Chem. 2010 Feb 25;53(4):1546-62.
Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptor.
Jiang J, Ganesh T, Du Y, Thepchatri P, Rojas A, Lewis I, Kurtkaya S, Li L, Qui M, Serrano G, Shaw R, Sun A, Dingledine R
Proc Natl Acad Sci U S A. 2010;107(5):2307-12.
A uHTS approach for the identification of beta-adrenoceptor ligands.
Tasler S, Baumgartner R, Aschenbrenner A, Ammendola A, Wolf K, Wieber T, Schachtner J, Blisse M, Quotschalla U, Ney P
Bioorg Med Chem Lett. 2010;20(11):3399-404.
The metabotropic glutamate receptor mGlu7 activates phospholipase C, translocates munc-13-1 protein, and potentiates glutamate release at cerebrocortical nerve terminals
Martín R, Durroux T, Ciruela F, Torres M, Pin JP, Sánchez-Prieto J.
J Biol Chem. 2010;285(23):17907-17.
GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models.
Lu X, Roberts E, Xia F, Sanchez-Alavez M, Liu T, Baldwin R, Wu S, Chang J, Wasterlain CG, Bartfai T
Proc Natl Acad Sci U S A. 2010;107(34):15229-34.
Fully human monoclonal antibodies antagonizing the glucagon receptor improve glucose homeostasis in mice and monkeys
Yan H, Gu W, Yang J, Bi V, Shen Y, Lee E, Winters KA, Komorowski R, Zhang C, Patel JJ, Caughey D, Elliott GS, Lau YY, Wang J, Li YS, Boone T, Lindberg RA, Hu S, Véniant MM.
J Pharmacol Exp Ther. 2009;329(1):102-11.
Inhibition of heterotrimeric G protein signaling by a small molecule acting on Galpha subunit.
Ayoub MA, Damian M, Gespach C, Ferrandis E, Lavergne O, De Wever O, Baneres JL, Pin JP, Prevost GP
J Biol Chem. 2009;284(42):29136-45.
Anorexia induced by activation of serotonin 5-HT4 receptors is mediated by increases in CART in the nucleus accumbens
Jean A, Conductier G, Manrique C, Bouras C, Berta P, Hen R, Charnay Y, Bockaert J, Compan V
Proc Natl Acad Sci U S A. 2007;104(41):16335-40
Real-Time Analysis of Agonist-Induced Activation of Protease-Activated Receptor 1/Galpha i1 Protein Complex Measured by Bioluminescence Resonance Energy Transfer in Living Cells
Ayoub MA, Maurel D, Binet V, Fink M, Prézeau L, Ansanay H, Pin JP.
Mol Pharmacol. 2007;71(5):1329-40
Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor.
Soga T, Ohishi T, Matsui T, Saito T, Matsumoto M, Takasaki J, Matsumoto S, Kamohara M, Hiyama H, Yoshida S, Momose K, Ueda Y, Matsushime H, Kobori M, Furuichi K
Biochem Biophys Res Commun. 2005;326(4):744-51.
High throughput screening technologies for direct cyclic AMP measurement.
Gabriel D, Vernier M, Pfeifer MJ, Dasen B, Tenaillon L, Bouhelal R
Assay Drug Dev Technol. 2003;1(2):291-303.




© 2012 Cisbio.com - All Rights Reserved